- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
An annual feature Reva Pharma, participated at Japan (CPhI). | 19 April, 2017
As an annual feature Reva Pharma, participated at Japan (CPhI). A lecture was delivered by Dr. Sandhu on “Overlapping Healthcare & Pharma Vision: Japan & India on 19th April 2017. The audience comprised of over 250 participants from the pharma fraternity, trade associations and government bodies.